Physical therapy is one of healthcare's most fragmented sectors. About 37,000 outpatient clinics operate across the country. Roughly 75% remain independently owned. The five largest platforms, according to Livingstone Partners' PT Tracker, hold only 20% of clinic market share combined.
That is a consolidation opportunity. For ETA buyers focused on lower-middle-market healthcare, the math is straightforward: recurring insurance revenue, a documented workforce shortage driving independent owners toward the exits, and valuation multiples that remain accessible on SBA financing.
This sector is not easy. Medicare reimbursement cuts squeezed independent operators for five consecutive years through 2025. Credentialing timelines create post-close cash flow gaps that surprise first-time buyers. Payer mix will make or break your valuation.
Know those risks going in. Here is what you need to evaluate before making an offer.
The demand tailwind is real
The Bureau of Labor Statistics projects 21% growth in physical therapist employment demand through 2030. The American Physical Therapy Association's 2025 Workforce Forecast puts the current shortage at 12,070 full-time equivalent therapists, a 5.2% gap relative to demand. That shortfall is projected to peak at 8.2% in 2027.
Rising demand. Constrained supply. Independent operators under reimbursement pressure. All of those forces push clinic owners toward selling or affiliating with a platform.
The industry runs about $56.4 billion in annual revenue (2026 estimate, Livingstone Partners). The top 50 competitors capture only 29% of that revenue. The rollup thesis is intact. Most buyers have not figured out how to execute it at the single-clinic entry level.
Valuation ranges you will actually see
Small PT practices trade on seller discretionary earnings. Larger ones trade on adjusted EBITDA after a quality-of-earnings review.
According to CT Acquisitions' 2026 M&A multiples report, which draws on BizBuySell NAICS 621340 data and IBBA Market Pulse Q4 2025 healthcare aggregates, the current ranges look like this:
- Sub-$500K SDE: 3.0x to 5.0x
- $500K to $1M SDE: 4.5x to 6.5x
- $1M to $3M adjusted EBITDA: 5.5x to 8.0x
- $3M to $10M adjusted EBITDA: 7.5x to 10.5x
Provident Healthcare Partners notes a 200 to 300 basis point premium for specialty concentration in sports medicine, pediatrics, or pelvic health. The five-year whole-market average sits at 3.6x EBITDA (Breakwater M&A, citing WebPT industry data). Platform deals at scale trade around 9x to 13x. Your entry point as a searcher is the 3.5x to 7x band.
Two variables move the multiple more than anything else. First: commercial payer weighting. Practices with more than 55% commercial insurance reach the top of their size band. Medicare-heavy practices take discounts. Second: referral concentration. A single referral source accounting for more than 25% of patient volume is a valuation ceiling, not just a risk factor.
How the deal stack works
SBA 7(a) is the standard financing vehicle for sub-$5M PT acquisitions.
Structure: up to $5M loan amount, 10-year term for business acquisition, with commercial real estate extending to 25 years. Healthcare lenders typically require 15% to 20% equity injection on PT deals, above the SBA minimum of 10%, due to intangible goodwill and key-person concentration common in single-location practices. On a $2M acquisition, that means $300K to $400K in buyer equity at close.
Seller notes appear on most PT deals. The typical range is 5% to 15% of purchase price. Under SBA SOP 50 10 8, the seller note must sit on full standby for 24 months. No principal. No interest. That means the seller is betting on your ability to run the clinic without her. Structure the transition agreement to support that bet.
The selling therapist usually stays on a consulting basis for 60 to 120 days post-close. Use that window. Introductions to referring physicians matter more than any other handoff task.
What due diligence looks like in PT
Standard business acquisition diligence applies. QoE on EBITDA, lease review, clean title. In PT, three items go beyond the standard checklist.
Payer mix. Pull three years of billing records by payer. Calculate Medicare, Medicaid, commercial, workers comp, and cash-pay percentages. Medicare concentration above 40% to 50% triggers lender scrutiny and valuation discounts. Know this number before you build your model.
OIG exclusion check. Any owner or clinical staff listed on the HHS Office of Inspector General exclusion list is a disqualifier. Medicare will not reimburse services provided by or under the supervision of an excluded individual. Check every clinician. This is not optional.
Referral source concentration. Map the top five referral sources by patient volume. A single orthopedic group driving 40% of your referrals is a single point of failure. Price that risk into your offer, not your integration plan.
The credentialing gap most buyers miss
In an asset purchase, the new entity must re-enroll with Medicare under a new Provider Transaction Access Number (PTAN). That process takes 60 to 180 days. During that window, the new entity cannot bill Medicare directly.
The workaround is a transition services agreement that allows billing under the seller's National Provider Identifier during the credentialing period. Negotiate this before signing the purchase agreement. Without it, you will fund 90 days of payroll from your own pocket while the government processes paperwork.
Similar timelines apply to Medicaid and some commercial credentialing. Build them into your cash flow model at close.
State-level corporate structure rules
Physical therapy is regulated at the state level. Several states impose corporate practice of medicine restrictions that govern who can own a PT clinic.
Washington State held in 2010 that physical therapy falls under the practice of medicine under state law, requiring conformance with professional service corporation rules. South Carolina prohibits referral fee arrangements between physical therapists and physician employers.
Before you sign a letter of intent, confirm that your acquisition structure complies with the target state's PT licensing and corporate ownership rules. This is a one-time legal review. Do not skip it.
The add-on thesis
A single clinic is a job. A platform is a business.
If your model depends entirely on one acquisition, your risk is concentrated. The PT rollup playbook works because the sector is fragmented enough to support serial add-on acquisitions in the same geography. Livingstone Partners has tracked roughly 500 add-on transactions in outpatient PT since 2005. Scale the administrative function. Keep the clinical teams clinic-level.
Industrial and on-site workplace therapy is one overlooked angle. Companies like Athletico and U.S. Physical Therapy have built employer-paid on-site programs that reduce commercial payer dependence. That model is replicable at smaller scale with the right employer relationships.
The South and West remain the most underpenetrated regions relative to population growth. Demographic migration is doing your market development work for you.
Related reading: How to buy a business with seller financing.
The one thing most PT buyers get wrong
They underestimate owner dependency.
If the selling therapist performs 40% or more of billable hours, you do not have a business. You have a practice built around one person. Lenders flag this. So should you.
The fix is not a long transition period. It is hiring a lead therapist before close, building the referral relationships in your own name during due diligence, and structuring the seller note around patient retention milestones rather than elapsed calendar time.
A PT practice at 4x to 6x adjusted EBITDA with clean payer mix, diversified referrals, and an employed clinical team is a strong ETA acquisition. One where the owner is the practice is not.
Know the difference before you issue a letter of intent.
Frequently Asked Questions
What is the typical valuation multiple for buying a physical therapy practice?
Practices with $500K to $1M in seller discretionary earnings trade at 4.5x to 6.5x SDE, according to CT Acquisitions citing IBBA and BizBuySell 2025 data. Practices with $1M to $3M in adjusted EBITDA trade at 5.5x to 8.0x. Specialty concentration in sports medicine, pediatric, or pelvic health adds a 200 to 300 basis point premium.
Can you use an SBA 7(a) loan to buy a physical therapy practice?
Yes. SBA 7(a) is the standard financing vehicle for outpatient PT acquisitions under $5M. Healthcare lenders typically require 15% to 20% equity injection due to key-person concentration and intangible goodwill. A seller note of 5% to 15% of purchase price is common and must sit on full standby for 24 months under SBA SOP 50 10 8.
What is the Medicare PTAN credentialing gap and how do you handle it?
In an asset purchase, the new ownership entity must re-enroll with Medicare under a new Provider Transaction Access Number. That process takes 60 to 180 days. Negotiate a transition services agreement with the seller before signing the purchase agreement to allow billing under the seller's existing NPI during the credentialing period. Budget for reduced Medicare cash flow in the first 90 days post-close.
What payer mix should you target when buying a physical therapy practice?
Commercial payer weighting above 55% supports top-band valuation multiples. Medicare concentration above 40% to 50% triggers lender scrutiny and price discounts. Cash-pay and specialty niches such as pelvic health and sports performance command the highest premiums and the most favorable financing terms.
